Find Academic Supervisors

Hyun (Michel) Koo is a Professor at the University of Pennsylvania School of Dental Medicine , with affiliations in the Department of Orthodontics , Division of Community Oral Health , and Division of Pediatric Dentistry . As Co-Founder and Co-Director of the Center for Innovation & Precision Dentistry (CiPD) , he leads interdisciplinary efforts merging bioengineering, nanotechnology, and oral health research. Education : DDS and PhD Research Focus : Biofilms, bacterial-fungal interactions, and nanotechnology for oral disease prevention Leadership : Co-Director of CiPD; key roles in training programs like NIDCR-sponsored R90 and T90/R90 Dr. Koo’s research explores biofilm mechanisms in oral infectious diseases, particularly childhood caries, through engineering methods and microrobotics . His team developed micron-scale robots for automated biofilm eradication and FDA-approved nanoparticles for caries prevention. Collaborations with Penn Engineering, including Dr. Daeyeon Lee and Dr. Kacy Cullen, emphasize translational approaches. The 15 most recent publications highlight his work in nanorobotics , interkingdom biofilms , and precision diagnostics . Articles span 2025–2024 and address topics like adaptive micromotors , biofilm matrix degradation , and single-cell microbial interactions . These emphasize his focus on targeted therapies and biofilm microenvironment engineering . Key Awards : Elected Fellow, American Association for the Advancement of Science (AAAS) IADR Distinguished Scientist Award for innovative dental research Dr. Koo trains next-generation researchers through the CiPD NIDCR T90/R90 Postdoctoral Training Program , mentoring fellows like Smruti Nair (ACE2 Chewing Gum development) and Zhi Ren (K99 awardee). His work intersects with Penn Health-Tech, CT3N , and Penn Institute for Biomedical Informatics , fostering transdisciplinary innovation.

• Biofilms
• Oral Infectious Diseases
• Nanotechnology
• +3 more

Ashli Owen-Smith is a behavioral scientist affiliated with the School of Public Health at Georgia State University , where her research focuses on mental health disparities, suicide prevention, and integrative/complementary approaches for complex mental-physical health conditions. She works with underserved populations including refugees/immigrants, incarcerated individuals, and LGBTQ+ communities through community-based participatory research and mixed-methods frameworks. Her current projects are funded by CDC , DBHDD , and DPH . Education: Ph.D. in Behavioral Sciences (Emory, 2009), S.M. in Public Health (Harvard, 2005), B.A. in Psychology (Smith College, 2001) Her research spans mental health , trauma , suicide prevention , and mindfulness-based interventions . Recent work examines telehealth adaptations for chronic pain and mental health, vaccine hesitancy in refugee communities, and social determinants of suicide . She leads studies on gender-affirming care and health disparities in LGBTQ+ populations. Key article trends include epidemiological analysis of suicide risk factors, COVID-19 impacts on mental health, ICD-10 coding for autism, and complementary medicine in trauma recovery. Subfields span telehealth , health equity , mental-physical comorbidity , and community engagement . Students she has mentored include C.A. Scarlett , T. Griner , and M.M. Sesay . Her work integrates public health policy , clinical research , and health systems analysis .

• Mental Health
• Behavioral Science
• Trauma
• +6 more

Todd A. Alonzo is a Professor of Research in the Department of Preventive Medicine at the University of Southern California . As Group Statistician for the Children's Oncology Group , he focuses on statistical methods for biomarker analysis, medical diagnostic testing, and clinical trial design in pediatric acute myeloid leukemia (AML). Education: B.S. in Statistics, California State Polytechnic University (1994) MS and PhD in Biostatistics, University of Washington (1997, 2000) Research Interests include: Development of statistical frameworks for diagnostic accuracy Genomic and proteomic profiling in AML Pharmacogenomic score systems for chemotherapy response Non-inferiority trial design in low-event-rate settings Health disparities in pediatric oncology Scientific Awards : Fellow, American Statistical Association (2018) Outstanding Teacher Award, International Society for Magnetic Resonance in Medicine (2017) NIH Predoctoral Cardiovascular Biostatistics Training Grant (1995) ENAR Biometrics Society Distinguished Student Paper Award (1999) WNAR Biometrics Society Best Student Oral Presentation (1999) Leadership & Service includes editorial board memberships (Biometrics, Pediatric Blood & Cancer, Biometrical Journal), reviewer for 30+ scientific journals, and roles on multiple Data Safety and Monitoring Boards. He served as President of the International Biometric Society Western Northern America Region (WNAR) in 2009.

• Statistical Methods in Biomedical Research
• Biomarker Analysis
• Clinical Trial Design
• +7 more

Jeremy Wang, PhD is an Assistant Professor in the Department of Genetics at the UNC School of Medicine . His research focuses on applying high-performance computational methods and machine learning to analyze high-throughput sequence data using long-read technologies (e.g., Oxford Nanopore) to advance precision personalized medicine . Key disease areas include Inflammatory Bowel Diseases (IBD) Respiratory Infectious Diseases His lab specializes in microbiome analysis , host-pathogen interactions , and computational genomics , working with collaborators in clinical, translational, and computational domains. His publications demonstrate expertise in long-read sequencing applications for Pediatric cancer classification SARS-CoV-2 genomic epidemiology Microbiome spatiotemporal dynamics Murine disease models Drosophilid genome assemblies Metagenomic bias analysis Collaborations span UNC and global institutions, with current work extending to clinical laboratory partnerships for pathogen sequencing and oral microbiome sampling methodology.

• Computational Biology
• Genomics
• Microbiome Research
• +7 more

Santiago Barreda is an Associate Professor in the Department of Linguistics at the University of California, Davis, specializing in speech perception and phonetic analysis. His research examines how acoustic properties of speech convey speaker characteristics including age, gender, and physical attributes. Education: Ph.D. in Linguistics (Phonetics), University of Alberta, 2013 M.A. in Hispanic Studies (Language and Linguistics), University of Western Ontario, 2008 B.A. in Linguistics and Spanish Language and Literature, University of Western Ontario, 2006 Research Focus: Dr. Barreda employs behavioral experiments and statistical modeling to investigate perceptual mechanisms in speech recognition. His work bridges theoretical phonetics with practical applications, particularly in vowel normalization techniques and formant tracking algorithms. Key questions address how listeners extract speaker identity from acoustic cues and interpret social characteristics through vocal signals. Publication Trends: Recent publications (2020-2025) reveal three dominant themes: computational phonetic tools (FastTrack, phonTools), perception of social/physical speaker characteristics from children's voices, and interdisciplinary public health research on speech-related aerosol transmission. His work demonstrates strong methodological consistency in combining acoustic analysis with perceptual validation. Scientific Awards: No scientific awards were mentioned in the source material. Advising and Grants: The provided documentation does not specify graduate student advising roles or external grant funding. Technical Contributions: Dr. Barreda develops open-source phonetic analysis software including FastTrack (Praat-based formant tracking) and the phonTools R package, which have become standard resources in acoustic phonetic research.

• Speech Perception
• Phonetics
• Acoustic Phonetics
• +4 more

Betsy Foxman serves as the Hunein F. and Hilda Maassab Professor of Epidemiology at the University of Michigan School of Public Health. She directs three major initiatives: the Center for Molecular and Clinical Epidemiology of Infectious Diseases, the Integrated Training in Microbial Systems program, and the Certificate in Healthcare Infection Prevention & Control. Her academic leadership spans decades with continuous research contributions. Dr. Foxman earned her PhD and MSPH from UCLA (1983, 1980) and BS from UC Berkeley (1977). Her research centers on infectious disease transmission, microbiome ecology, antibiotic resistance, and wastewater surveillance . Key projects include analyzing the oral microbiome in dental caries using genomic methods, studying nose/throat microbiome associations with respiratory infections in nursing facilities, and developing wastewater monitoring for antibiotic-resistant pathogens. Her work integrates next-generation sequencing with epidemiological analysis to identify novel interventions. Publication trends reveal consistent focus on microbiome-pathogen interactions across multiple body sites (oral, vaginal, gut, respiratory). Recent articles demonstrate methodological innovation in wastewater epidemiology (2024 Norovirus GII monitoring) and clinical applications like predicting vancomycin-resistant enterococci contamination (2023 Lancet study). Her research bridges molecular microbiology with population health, emphasizing translational potential for diagnostics and public health interventions. Fellow of the Infectious Disease Society of America Fellow of the American College of Epidemiology Fellow of the American Academy of Microbiology Dr. Foxman's advising portfolio includes numerous NIH-funded projects on microbiome dynamics and infection control. Her leadership in the Center for Molecular and Clinical Epidemiology drives collaborative research across departments. Current initiatives focus on wastewater surveillance standardization and microbiome-based diagnostics for infection prevention. She maintains active laboratories for genomic analysis of microbial communities and clinical sample processing.

• Infectious Disease Epidemiology
• Human Microbiome Research
• Antibiotic Resistance
• +5 more

Timothy J. Muldoon is a Professor in the Department of Biomedical Engineering at the University of Arkansas, where he has been since 2012. He holds joint appointments in the (ENGR)-Engineering and (BMEG)-Biomedical Engineering programs. B.S. in Biomedical Engineering from Johns Hopkins University (2002) Ph.D. in Bioengineering from Rice University (2009) M.D. from Baylor College of Medicine (2010) Dr. Muldoon leads the Translational Biophotonics and Imaging Laboratory, focusing on multimodal microendoscopy , multiphoton imaging , and light sheet microscopy for cancer detection and treatment monitoring. His work bridges optical spectroscopy , nanotechnology , and microfluidics to develop novel diagnostic tools. Current research includes optical methods for assessing chemoradiotherapy response in colorectal cancer, metabolic imaging of tumor organoids , and point-of-care blood analysis systems . His publications (30+ peer-reviewed articles) and NIH-funded projects demonstrate clinical translation of optical biopsy technologies. National Institutes of Health Academic Research Enhancement Award (R15) - Cancer Imaging NIH Early Career Reviewer Program (2016) Burroughs Wellcome Collaborative Research Grant (2012) Dr. Muldoon teaches advanced courses in Biomedical Microscopy (BMEG 5504) and Biomedical Instrumentation (BMEG 2904), emphasizing optical techniques and physiological measurements . He has received multiple teaching and service awards at the University of Arkansas.

• Biomedical Engineering
• Biophotonics
• Cancer Research
• +5 more

Julia Cummiskey is an Assistant Professor in the Department of the History of Medicine at Johns Hopkins University. Her research focuses on the history of global health, biomedicine in Africa, epidemics, and public health campaigns. She is particularly interested in the intersections of global health practices with local contexts in East Africa. Dr. Cummiskey’s work combines archival research, oral histories, and collaborative projects with researchers in Africa. Her current project, Selling Health , examines the evolution of health communication strategies in East Africa from the 20th to 21st centuries, exploring how health-related products and behaviors were marketed through campaigns, commercial promotions, and informal channels. This work bridges African history, business history, and the history of medicine. Her research outputs include scholarly articles on topics such as AIDS research in Uganda, tuberculosis control in Baltimore, and colonial-era experimental fields in Bwamba, Uganda. She has also contributed to public health reporting through the Morbidity and Mortality Weekly Report . Dr. Cummiskey teaches courses on the history of science and medicine, including Health & Healing in Africa . She emphasizes interdisciplinary collaboration and the decolonization of global health narratives in her academic work.

• History of Global Health
• Biomedicine in Africa
• Epidemics
• +3 more

Catherine E. Costello is the William Fairfield Warren Distinguished Professor and Director of the Center for Biomedical Mass Spectrometry Education at Boston University School of Medicine. She holds a PhD and MS from Georgetown University. Her research focuses on biopolymer structural studies and mass spectrometry method development, particularly in glycobiology. Her lab is an NIH-funded Resource Center advancing glycan characterization and structural analysis. Key research interests include carbohydrate conjugate analysis, glycoproteomics, and applications in disease mechanisms like cancer, infection, and immune response. Collaborations span institutions globally, addressing complex biomolecules and their roles in health and disease. Recent publications highlight advancements in glycoproteomic characterization, ion mobility spectrometry, and glycan identification. Awards include the distinguished professor title. Lab members include postdoctoral associates, research staff, and visiting scientists from institutions like MGH and Nutricia Research.

• Biopolymer Structural Studies
• Mass Spectrometry Method Development
• Glycobiology
• +3 more

Patrick Bradley is an Assistant Professor of Microbiology at The Ohio State University, affiliated with the College of Arts and Sciences. He is also part of the Infectious Diseases Institute and the Center of Microbiome Science. His research focuses on understanding human microbiota (particularly the gut and oral microbiomes) using computational and experimental approaches. Bradley earned his A.B. from Harvard University (2005), Ph.D. from Princeton University (2012), and completed a postdoctoral fellowship at the University of California, San Francisco (2013–2020). Education: A.B., Harvard University, 2005 Ph.D., Princeton University, 2012 Postdoc, University of California, San Francisco, 2013–2020 His research interests include microbial gene function prediction, gene regulation in adaptive environments, and the role of microbiomes in drug metabolism and disease. Current lab projects involve leveraging natural genetic variation to identify genes influencing microbial colonization, understanding regulatory mechanisms in microbial adaptation, and developing machine learning tools for functional annotation. Recent work highlights the disproportionate impact of genomic misassembly in metagenomic studies and the shared metabolic pathways between hosts and microbes in cancer drug processing. Bradley’s lab actively collaborates on projects such as PanSweep (a tool to detect pangenome contamination) and Phylogenize2 (for phylogeny-corrected gene association analysis). Advising and grants: Bradley mentors PhD students (Christian J. Quiles Pérez, Stephanie Majernik, Nghi Tran, Alexis Young) and has contributed to studies exploring microbiome-modulating therapies. The Bradley Lab is part of interdisciplinary initiatives at Ohio State, emphasizing translational research in microbiome science. Lab activities include developing computational tools for microbiome analysis and maintaining collaborations with institutions like the Center for Microbiome Science. The lab’s work has implications for precision medicine and understanding microbial contributions to human health.

• Human microbiome
• Bioinformatics
• Genomics
• +4 more

Michael Rosenzweig, M.D., M.S., serves as Associate Professor and Chief of the Division of Multiple Myeloma in the Department of Hematology & Hematopoietic Cell Transplantation at City of Hope. A board-certified hematologist-oncologist, he directs the amyloidosis program and specializes in plasma cell disorders including multiple myeloma, AL amyloidosis, Waldenstrom macroglobulinemia, and POEMS syndrome. His educational background includes: B.A. in Psychology from Emory University (1989-1993) M.S. in Physiology and Biophysics (1993-1994) M.D. from University of Arizona College of Medicine (1997-2001) Internal Medicine Residency and Hematology/Oncology Fellowship at Boston Medical Center (2001-2009) Bone Marrow Transplantation Fellowship at Memorial Sloan Kettering Cancer Center (2009-2011) Dr. Rosenzweig's research focuses on novel therapeutic strategies for plasma cell disorders, with particular emphasis on smoldering myeloma intervention and amyloidosis treatment optimization. He actively investigates drug repurposing (leflunomide), monoclonal antibodies (daratumumab), and CAR-T therapies targeting CS1 for light chain amyloidosis. His clinical work involves multidisciplinary collaboration with cardiology, nephrology, and neurology for comprehensive amyloidosis management. His publication record demonstrates consistent focus on translational and clinical research in plasma cell malignancies, with recent work spanning from preclinical CAR-T studies to phase I/II trials of novel combinations for relapsed/refractory disease. Key themes include treatment sequencing, biomarker development, and addressing rare amyloid subtypes. Scientific recognition includes: 2021 IDEA Grant for AL amyloidosis detection 2020 Pfizer grant for TTR amyloidosis management (Co-PI) 2018 Steven Gordon Innovation Grant 2015 David Seldin Research Grant 2013 ASBMT Clinical Research Scholar As an educator, Dr. Rosenzweig mentors hematology-oncology fellows and leads clinical trials through industry partnerships and investigator-initiated grants. His current research portfolio emphasizes diagnostic pathway optimization and therapeutic strategies for precursor conditions. He practices at Duarte Cancer Center with active involvement in the plasma cell disease team and hematopoietic cell transplantation program.

• Multiple Myeloma
• Amyloidosis
• Hematology
• +5 more

Christine Moe is a Professor and the Eugene J. Gangarosa Chair in Safe Water and Sanitation at Emory University’s Rollins School of Public Health. Her primary appointment is in the Hubert Department of Global Health, with joint roles in Environmental Health and Epidemiology. She holds a PhD from the University of North Carolina and has conducted postdoctoral research at the CDC. Moe’s research focuses on environmental transmission of pathogens, particularly noroviruses and waterborne diseases, with fieldwork in over 30 countries. Her work includes studies on sanitation systems, water quality, and wastewater surveillance. She directs Emory’s Center for Global Safe Water, emphasizing global health equity. Awards include the prestigious Eugene J. Gangarosa Chair. Her contributions span lab-based viral studies and community-level interventions to improve water and sanitation in low-resource settings. Education: PhD in Environmental Sciences (UNC-Chapel Hill), MS in Environmental Science (UNC), BA in Biology (Swarthmore College). Research Interests: Environmental health, waterborne pathogens, norovirus transmission, and global sanitation infrastructure. She has pioneered wastewater-based epidemiology to monitor disease outbreaks and assess public health risks in healthcare and urban environments.

• Global Health
• Infectious Disease
• Safe Water
• +3 more

Ram Samudrala is a Professor and Chief of the Division of Bioinformatics at the University at Buffalo Jacobs School of Medicine and Biomedical Sciences . His research focuses on multiscale computational biology , integrating protein structure prediction , drug discovery , and translational science to address medical challenges. He leads the development of the CANDO platform for therapeutic drug discovery and co-directs the Informatics Core at the Clinical and Translational Sciences Institute. PhD in Computational Biology (University of Maryland, 1997) BA in Computing Science and Genetics (Ohio Wesleyan University, 1993) Postdoctoral Fellowship in Protein Folding (Stanford University, 1997-2001) His work spans structural biology , genomics , and computational drug design , with applications in dentistry , infectious diseases , and cancer . He has received prestigious awards including the NIH Director's Pioneer Award (2010) and multiple Wiki Science Prizes . Samudrala's group collaborates globally, emphasizing in silico methods followed by in vitro and in vivo validation. Key grants include $1.22M NIH NCATS ASPIRE Reduction-to-Practice Award and $4.5M NIH/NLM BRIGHT Training Grant . 2023 Finalist, Clinical and Translational Sciences Institute Clinical Research Achievement Awards 2016 MacArthur Foundation 100&Change Top 50 2008 Alberta Heritage Foundation Visiting Scientist Award 2005 NSF CAREER Award He directs the BRIGHT Short-Term Training Program and serves on multiple editorial boards and review panels. Samudrala's group maintains a Protinfo web server for structural predictions and the Bioverse framework for systems-level analyses.

• Bioinformatics
• Computational Biology
• Drug Discovery
• +10 more

Dr. Mahdi Hasani is an Assistant Research Professor in the Sibley School of Mechanical and Aerospace Engineering at Cornell University. His research focuses on biologically inspired immunomodulatory biomaterials, engineering advanced drug delivery systems for cancer therapy, infectious diseases, autoimmune conditions, and tissue regeneration. He explores innovative engineering platforms aimed at rejuvenating the immune system. Dr. Hasani holds two B.Sc. degrees in Polymer Engineering and Biomedical Engineering from Amirkabir University of Technology, two M.Sc. degrees in Polymer Engineering and Bioengineering from Amirkabir University of Technology and EPFL respectively, and two Ph.D. degrees in Polymer Engineering and Mechanical Engineering-Bioengineering from Amirkabir University of Technology and Georgia Institute of Technology. His publications demonstrate consistent focus on biomaterials, drug delivery systems, and immunoengineering with applications in cancer therapy and regenerative medicine. Research trends include nanoparticle therapeutics, hydrogel biomaterials for tissue regeneration, and T-cell immunomodulation strategies. Scientific Awards and Honors: Technology in Space Prize (2024) Faculty Innovation Fellow, UCLA (2021) Healthcare Innovation Challenge Award (2021) Sigma Xi Best Ph.D. Thesis Award (2018) Early Career Board, ACS Biomaterials Science & Engineering (2018) Young Khwarizmi Award (multiple years) Dr. Hasani co-founded three biotech startups and has over 12 U.S. patents, several licensed. His work bridges polymer engineering, microfluidics, and immunoengineering to develop transformative biomedical solutions.

• Bioengineering
• Drug Delivery
• Microfluidics
• +4 more

Dr. Kannan Ramar is a Physician Scientist at the Mayo Clinic School of Graduate Medical Education within the Mayo Clinic College of Medicine and Science . His dual expertise in Pulmonary Medicine and Sleep Medicine spans clinical practice, research, education, and quality improvement initiatives. MBA from University of Minnesota (2024) Board Certifications: Sleep Medicine (ABIM, ABMS), Critical Care, Pulmonary Disease Leadership Roles: Assistant Dean, Chair of American Academy of Sleep Medicine committees His research focuses on sleep disorders (apneas, REM behavior disorder), critical care quality improvement , and risk communication . Recent work includes updated oral appliance therapy guidelines for sleep apnea and pandemic-era telemedicine adaptations in sleep medicine. Publications in J Clin Sleep Med and Chest highlight his contributions to clinical protocols and quality metrics. Dr. Ramar has received 16 teaching and research awards since 2005, including the 2022 EPITOME Educator Award and 2021 Diamond Lifetime Achievement Award . As a section editor for Mayo Clinic Proceedings and Fellow of multiple societies, he shapes national standards in sleep medicine and ICU safety.

• Sleep Medicine
• Critical Care Medicine
• Pulmonary Disease
• +3 more